New Drug Submission meeting scheduled with Health Canada for the third quarter of 2025Initial briefing book submitted for review to the European Medicines Agency WARREN, N.J., July 15, 2025 (GLOBE ...

Number of schemes are being implemented to realise the vision of Atmanirbhar Bharat in the pharmaceutical sector and to ...

Aquestive Therapeutics, Inc. (NASDAQ: AQST) ("Aquestive" or the "Company"), a pharmaceutical company advancing medicines to bring meaningful improvement ...

New Drug Submission meeting scheduled with Health Canada for the third quarter of 2025Initial briefing book submitted for review to the European Medicines Agency WARREN, N.J., July 15, 2025 (GLOBE NEW ...

The dispute between two restaurants with the same name on the same block underscores a weakness in the state's trademark ...

Biodexa Pharmaceuticals PLC ("Biodexa” or "the Company”), (Nasdaq: BDRX), a clinical stage biopharmaceutical company ...

Under the non-binding term sheet, Quazar intends to lead a capital formation round of up to $50 million, priced at $25 per share. The proposed structure allocates 70% of proceeds to the acquisition of ...

We asked experts for their thoughts on the best peptide serums, checked our vanities, and sifted through reviews to compile this short list of top picks.

The startup Gigablue announced with fanfare this year that it reached a historic milestone: selling 200,000 carbon credits to fund what it describes as a groundbreaking technology in the fight against ...

A startup called Gigablue claims to have reached a milestone by selling 200,000 carbon credits for its ocean-based carbon capture technology. The company says its patented particles grow algae ...

Company touted Kisqali's "replacement power" as another blockbuster faces generic competition and expressed optimism about ...